Malaysia
# |
Name |
Price to Sales Ratio (P/S) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
4.36 |
Jan. 14, 2025 | USD 0.25 | -1.78% |
|
Malaysia |
|
2 |
3.51 |
Jan. 14, 2025 | USD 0.27 | -0.87% |
|
Malaysia |
|
3 |
2.96 |
Jan. 14, 2025 | USD 0.51 | -1.32% |
|
Malaysia |
|
4 |
2.90 |
Jan. 14, 2025 | USD 0.94 | -2.12% |
|
Malaysia |
|
5 |
1.72 |
Jan. 14, 2025 | USD 0.27 | -1.64% |
|
Malaysia |
|
6 |
0.80 |
Jan. 14, 2025 | USD 0.43 | -2.04% |
|
Malaysia |
|
7 |
0.59 |
Jan. 14, 2025 | USD 0.22 | -0.04% |
|
Malaysia |
The Health Care company in Malaysia with the highest Price to Sales Ratio (P/S) is Supermax Corporation Berhad (Kuala Lumpur Stock Exchange: 7106.KL) at 4.36.
The Health Care company in Malaysia with the lowest Price to Sales Ratio (P/S) is Ancom Nylex Berhad (Kuala Lumpur Stock Exchange: 4758.KL) at 0.59.
The top 10 Health Care companies in Malaysia by Price to Sales Ratio (P/S) are Supermax Corporation Berhad, Top Glove Corporation Bhd., KPJ Healthcare Berhad, Kotra Industries Berhad, Duopharma Biotech Berhad, 7-Eleven Malaysia Holdings Berhad and Ancom Nylex Berhad.
The bottom 10 Health Care companies in Malaysia by Price to Sales Ratio (P/S) are Ancom Nylex Berhad, 7-Eleven Malaysia Holdings Berhad, Duopharma Biotech Berhad, Kotra Industries Berhad, KPJ Healthcare Berhad, Top Glove Corporation Bhd. and Supermax Corporation Berhad.